Europe
EIB and German specialty pharmaceutical company PAION AG have signed a EUR 20 million loan agreement
The European Investment Bank will lend up to €20 million to PAION AG, a German pharmaceutical company specialised in anaesthesia and sedation drugs.
Biotage AB, is pleased to announce the launch of the Biotage® VacMaster™ Disk, a vacuum extraction unit for performing manual, disk-based extractions of semi-volatile organic compounds and hexane-extractable materials from aqueous matrices.
Guiding chemotherapy to a tumour by attaching it to the antibody-based target drug Herceptin is effective at treating women with breast cancer who have no other treatment options, a new clinical trial shows.
Darzalex in combination with lenalidomide and dexamethasone was approved as a first-line treatment for multiple myeloma patients who are ineligible for autologous stem cell transplant.
Driving personalized, immune-based therapy to target patients’ own immune responses
Velabs Therapeutics GmbH announced the closing of a €3 million Series B financing round to advance its functional antibody screening programme and to strengthen its own pipeline of preclinical functional antibodies against diseases with poor treatment options.
The Micronic Tube Reader DT500 is high-speed storage tube code reading at its best.
Speak up and be heard—never before have these words pertained to lab work quite the way they do now: thanks to COATINO™, the first digital laboratory assistant that Evonik is developing especially for the coatings industry.
Sartorius Stedim Biotech (SSB) launched a new vessel for its ambr® 250 modularbenchtop automated mini bioreactor system.
Pain, fluids, odor—and endless dressing changes: Chronic wounds often fail to close, and patients’ bodies appear unable to heal.
PRESS RELEASES